“Experience in Switching Monoclonal Antibodies in a Patient With Severe Refractory Atopic Dermatitis: From Dupilumab to Abrocitinib. Case Report ”. Revista Alergia México 72, no. 4 (December 19, 2025): 382–385. Accessed September 24, 2026. https://www.revistaalergia.mx/ojs/index.php/ram/article/view/1547.